Planegg, Germany · Founded 2010 · Privately Held (backing)
Developer of drugs through nanoscience designed to offer patient outcomes. Leon Nanodrugs is based in Planegg, Germany and was founded in 2010. Its last reported valuation was $71 million in Jul 2015. It has raised $20.5 million.
Last reported valuation
$71.0M
Oct 2026
Priced at
—
Total raised
$20.5M
Last round
—
Team — not yet on record
No current team members for Leon Nanodrugs are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Leon Nanodrugs with a free account
·The complete investor list: 11 names
·Watch Leon Nanodrugs: the Monday email on marks, rounds and moves
